Company Staidson (Beijing) BioPharmaceuticals Co., Ltd.
Equities
300204
CNE100001237
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.68 CNY | +3.09% | +6.03% | -34.25% |
Business Summary
Number of employees: 555
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Manufacturing
100.0
%
| 549 | 100.0 % | 364 | 100.0 % | -33.66% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 549 | 100.0 % | 364 | 100.0 % | -33.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chao Wang
CEO | Chief Executive Officer | 42 | 30/06/11 |
Shi Cheng Li
DFI | Director of Finance/CFO | 42 | 25/08/20 |
Zhi Wen Zhou
PSD | President | 59 | 31/12/01 |
Hong Shan Zhang
CHM | Chairman | 60 | 31/12/01 |
Rong Qin Zhang
BRD | Director/Board Member | 56 | 31/12/03 |
Ji Guang Zhao
PRN | Corporate Officer/Principal | 49 | 31/03/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Shan Zhang
CHM | Chairman | 60 | 31/12/01 |
Zhi Wen Zhou
CHM | Chairman | 59 | 31/12/01 |
Tao Li
BRD | Director/Board Member | 61 | 31/12/07 |
Rong Qin Zhang
BRD | Director/Board Member | 56 | 31/12/03 |
Xiao Yan Wang
BRD | Director/Board Member | 57 | 07/09/22 |
Ying Sun
BRD | Director/Board Member | 62 | 16/09/18 |
Hong Zheng
BRD | Director/Board Member | 53 | 10/08/21 |
Li Zhao
BRD | Director/Board Member | 67 | 10/08/21 |
Lian Chun Yang
BRD | Director/Board Member | 59 | 10/08/21 |
- | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 477,772,555 | 121,574,929 ( 25.45 %) | 0 | 25.45 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
INFLARX N.V. 9.74% | 5,733,910 | 9.74% | 8,830,221 $ |
Company contact information
Staidson (Beijing) Biopharmaceuticals Co., Ltd.
36 Jinghai 2nd Road Beijing Economic Tech Dev Area
100176, Beijing
+
http://www.staidson.comSector
1st Jan change | Capi. | |
---|---|---|
-34.25% | 441M | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- 300204 Stock
- Company Staidson (Beijing) BioPharmaceuticals Co., Ltd.